Medical News Today -
11 Dec 2013 12:00
New research presented during the 55th American Society of Hematology Annual Meeting and Exposition in New Orleans uncovers several important insights into the pathophysiology of sickle cell disease and thalassemia that may soon translate into the development of better, more targeted treatments for hundreds of thousands of patients worldwide.Sickle cell disease (SCD) is an inherited, chronic disorder affecting nearly 100,000 Americans.
Share this Article